# CADRE HOLDINGS, INC. (CDRE) · Edgar & Edgarette company card

> Cadre Holdings, Inc. (CDRE) grew revenue 7.5% in FY2025 to $610 million, operating margin 11.0%, in line with the 11.0% median for orthopedic, prosthetic & surgical appliances & supplies, equity 41.3% of assets, and dividend per share up 2 years running. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1860543 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/CDRE) · [JSON](https://www.pops4.com/boards/company/CDRE.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $610M |
| Revenue growth, 1 year | 7.5% |
| Revenue growth per year | 9.3% |
| Operating margin | 11.0% (prior year 11.8%) |
| Net margin | 7.2% |
| Operating cash flow | $64M |
| Capital spending | $7M |
| Free cash flow | $57M |
| Cash | $123M |
| Long-term debt | $307M |
| Total assets | $770M |
| Total equity | $318M |
| Equity ÷ assets | 41.3% |
| Return on equity | 13.9% |
| Dividend per share | $0.38 |
| Dividend years rising | 2 |

## Readings, computed from those figures

- Altman Z: 3.7 (safe zone)
- Piotroski F: 6 of 9 (solid)
- Health Harbor boat: New ship · no warning signs
- Cash Compass: Cash cow now · steady, with strong cash arriving today

## Edgarette's reading

Exposure: revenue $610.3M (FY2025), total debt $307.3M. Experience: revenue up 7.5% on the year, up 9.3% a year over 4 years; operating margin 11.0%, down from 11.8%. Soundness: equity 41.3% of assets, return on equity 13.9%, payout 35.0% of profit, dividend per share up 2 years running. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $570.3M and $742.1M next year (method v4.1: its own 4-year record of growth weighed at 50% against $100M–1B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $533.5M to $795.4M. A statistical range, not company guidance. Against peers (13 filers, $50M+ revenue, orthopedic, prosthetic & surgical appliances & supplies): operating margin 11.0% against a 11.0% median; growth 7.5% against 7.5%.

Range logged 2026-11-01, receipt be29a15bc4ec12b9, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 2, latest 2026-11-16 ([filing](https://www.sec.gov/Archives/edgar/data/1860543/000110465926127680/0001104659-26-127680-index.htm))

## Recent filings

- 8-K · filed 2026-11-16 · 5.02 Departure or Election of Directors; Appointment of Officers · [filing](https://www.sec.gov/Archives/edgar/data/1860543/000110465926127680/0001104659-26-127680-index.htm)
- 10-Q · filed 2026-11-04 · [filing](https://www.sec.gov/Archives/edgar/data/1860543/000110465926122697/0001104659-26-122697-index.htm)
- 8-K · filed 2026-11-04 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1860543/000110465926122686/0001104659-26-122686-index.htm)
- 10-Q · filed 2026-08-05 · [filing](https://www.sec.gov/Archives/edgar/data/1860543/000110465926091151/0001104659-26-091151-index.htm)
- 8-K · filed 2026-08-05 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1860543/000110465926091143/0001104659-26-091143-index.htm)
- 8-K · filed 2026-07-29 · 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1860543/000110465926088148/0001104659-26-088148-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001860543.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1860543

## Cite

POPS4, Edgar & Edgarette: CADRE HOLDINGS, INC. (CDRE) company card, from the company's own SEC filings, accessed 2026-11-17, https://www.pops4.com/boards/company/CDRE. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.

